Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Much Is the Global Precision Oncology Market Valued at Present and by 2029?
In the past few years, the size of the precision oncology market has witnessed rapid expansion. The market, estimated at $95.73 billion in 2024, is anticipated to escalate to $106.21 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. Factors contributing to growth during the historic phase include an increase in the approval of companion diagnostics, emphasis on the discovery and validation of biomarkers, growth in funding for oncology research and innovation, a higher number of clinical trials related to precision oncology, and an increased inclination towards less invasive diagnostic methods.
In the coming years, the precision oncology market is projected to witness substantial growth, with its size anticipated to reach $158.90 billion by 2029, progressing at a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this predicted growth during the forecast period include the rising number of cancer cases, the surging acceptance of genomics-based diagnostics, increased awareness among patients and medical professionals, the expanding use of next-generation sequencing and the growing need for targeted cancer treatments. Key trends for the forecast period are advancements in liquid biopsy technologies, the sophisticated use of single-cell sequencing in tumour analysis, the creation of decentralized testing platforms, innovations in radio genomics for treatment planning and progress in personalised cancer vaccines.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp
#What Drivers Are Influencing Growth In The Precision Oncology Market?
The growth of the precision oncology market is anticipated to surge due to the escalating comprehension and transition towards personalized therapies. These therapies are designed to fit a person’s genomic structure, biomarkers, and particular disease traits to amplify their efficacy and minimize their side effects. Progressions in genomic technologies are fostering the augmentation of personalized therapies by enabling the exact detection of mutations that cause diseases, which further permits the development of more successful and targeted treatments. Precision oncology bolsters personalized therapies through the utilization of genomic and molecular profiling, thereby calibrating cancer treatment to conform to a patient’s specific tumor genetics. As an example, according to GOV.UK, in February 2023, the Health and Social Care Secretary from a UK-based government bureau inked a Memorandum of Understanding (MoU) with BioNTech SE to boost cancer vaccine research in England with the goal to provide 10,000 personalized therapy doses to patients in the UK by 2030. Hence, the mounting comprehension and transition towards personalized therapies are propelling the expansion of the precision oncology market.
What Are The Main Segments Identified In The Precision Oncology Market Research?
The precision oncology market covered in this report is segmented
1) By Type: Genomic Sequencing, Immunotherapy
2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers
4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy
5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers
Subsegments:
1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing
2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy
What Are The Leading Trends And Opportunities In The Precision Oncology Sector?
Leading firms in the precision oncology market are utilizing inventive strategies, such as the molecular tumor board, to facilitate bespoke treatment decisions—melding genomic data with clinical context. The molecular tumor board is essentially a group of specialists tasked with examining and interpreting intricate genomic and molecular test results to provide precision-guided cancer treatments tailored to each patient’s specific tumor traits. For example, in December 2024, Aster DM Healthcare Ltd., a healthcare provider in the UAE, launched a precision oncology clinic as part of three personalized cancer care initiatives aimed at revolutionizing treatment using data-driven, genomic-centric methods. This clinic offers tailored cancer treatments derived from the patient’s tumor genetic makeup, allowing for more accurate and potent therapies with fewer side effects. This strategy boosts treatment success rates, reduces toxicity, and enhances the patient’s quality of life by tailoring treatments to the unique molecular attributes of an individual’s cancer.
Which Companies Play A Key Role In The Development Of The Precision Oncology Market?
Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report
What Are The Key Regional Developments Shaping The Precision Oncology Market?
North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model